Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 159 (RN7SKP159) is annotated as a **pseudogene** and is related by sequence homology to the functional non-coding RNA gene RN7SK. Pseudogenes are genomic DNA sequences similar to normal genes but generally non-functional; they often arise by gene duplication or retrotransposition and usually lack the regulatory elements or intact structure required to produce functional RNA or protein products. There is no evidence that RN7SKP159 produces a stable RNA or has an independent biological role. For comparison, the active **RN7SK** gene encodes 7SK small nuclear RNA, a highly conserved non-coding RNA that serves as a scaffold for the 7SK small nuclear ribonucleoprotein (snRNP) complex, which plays an essential role in regulation of transcription elongation by controlling the activity of the positive transcription elongation factor b (P-TEFb)[1][2][3][4]. Key additional points: - RN7SKP159 is not a **therapeutic target, receptor, enzyme, transporter, or transcription factor**. - There are **no known aliases** or common alternative names beyond the systematic pseudogene name. - It should not be confused with the functional **RN7SK** small nuclear RNA gene (also known as "RNA, 7SK small nuclear", "7SK")[1][3][4]. - **Pseudogenes** rarely encode functional products, but some can exert regulatory effects (e.g., as long non-coding RNAs or competing endogenous RNAs), although no such evidence is reported for RN7SKP159. In summary, **RN7SKP159**, as a pseudogene, is not an active molecule or recognized target in therapeutic, diagnostic, or biological contexts. The entry is **likely not relevant for drug targeting or clinical biomarker development**. If information about the **active RN7SK snRNA** is needed, this is a distinct entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 159 (RN7SKP159).